BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 29587669)

  • 1. Ezrin and E-cadherin expression profile in cervical cytology: a prognostic marker for tumor progression in cervical cancer.
    Zacapala-Gómez AE; Navarro-Tito N; Alarcón-Romero LDC; Ortuño-Pineda C; Illades-Aguiar B; Castañeda-Saucedo E; Ortiz-Ortiz J; Garibay-Cerdenares OL; Jiménez-López MA; Mendoza-Catalán MA
    BMC Cancer; 2018 Mar; 18(1):349. PubMed ID: 29587669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered expression of ezrin, E-Cadherin and β-Catenin in cervical neoplasia.
    Auvinen E; Carpen O; Korpela T; Ronty M; Vaheri A; Tarkkanen J
    Neoplasma; 2013; 60(1):56-61. PubMed ID: 23067217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of ezrin predicts poor prognosis in uterine cervical cancer.
    Kong J; Li Y; Liu S; Jin H; Shang Y; Quan C; Li Y; Lin Z
    BMC Cancer; 2013 Nov; 13():520. PubMed ID: 24182314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ezrin contributes to cervical cancer progression through induction of epithelial-mesenchymal transition.
    Kong J; Di C; Piao J; Sun J; Han L; Chen L; Yan G; Lin Z
    Oncotarget; 2016 Apr; 7(15):19631-42. PubMed ID: 26933912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPV-16 E6/E7 promotes cell migration and invasion in cervical cancer via regulating cadherin switch in vitro and in vivo.
    Hu D; Zhou J; Wang F; Shi H; Li Y; Li B
    Arch Gynecol Obstet; 2015 Dec; 292(6):1345-54. PubMed ID: 26093522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter Methylation of Ezrin and its Impact on the Incidence and Prognosis of Cervical Cancer.
    Qin R; Cao L; Wang J; Liu J
    Cell Physiol Biochem; 2018; 50(1):277-287. PubMed ID: 30282070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-risk HPV infection and CIN grade correlates to the expression of c-myc, CD4+, FHIT, E-cadherin, Ki-67, and p16INK4a.
    Samir R; Asplund A; Tot T; Pekar G; Hellberg D
    J Low Genit Tract Dis; 2011 Oct; 15(4):280-6. PubMed ID: 21558960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of Ezrin and E-cadherin in nasopharyngeal carcinoma and its significance].
    Wang L; Gao Y; Tu Q; Hong J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Sep; 35(9):969-75. PubMed ID: 20871163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The three most common human papillomavirus oncogenic types and their integration state in Thai women with cervical precancerous lesions and carcinomas.
    Aromseree S; Chaiwongkot A; Ekalaksananan T; Kongyingyoes B; Patarapadungkit N; Pientong C
    J Med Virol; 2014 Nov; 86(11):1911-9. PubMed ID: 25091234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-risk human papillomavirus infection and E6 protein expression in lesions of the uterine cervix.
    Pillai MR; Lakshmi S; Sreekala S; Devi TG; Jayaprakash PG; Rajalakshmi TN; Devi CG; Nair MK; Nair MB
    Pathobiology; 1998; 66(5):240-6. PubMed ID: 9732239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined expression of ezrin and E-cadherin is associated with lymph node metastasis and poor prognosis in breast cancer.
    Yu Z; Sun M; Jin F; Xiao Q; He M; Wu H; Ren J; Zhao L; Zhao H; Yao W; Shan F; Cao Y; Wei M
    Oncol Rep; 2015 Jul; 34(1):165-74. PubMed ID: 25955302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interest of human papillomavirus DNA quantification and genotyping in paired cervical and urine samples to detect cervical lesions.
    Ducancelle A; Legrand MC; Pivert A; Veillon P; Le Guillou-Guillemette H; De Brux MA; Beby-Defaux A; Agius G; Hantz S; Alain S; Catala L; Descamps P; Postec E; Caly H; Charles-Pétillon F; Labrousse F; Lunel F; Payan C
    Arch Gynecol Obstet; 2014 Aug; 290(2):299-308. PubMed ID: 24622934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of cervical human papillomavirus (HPV) infection and squamous intraepithelial lesions (SIL) among a cohort of HIV-infected and uninfected Ghanaian women.
    Obiri-Yeboah D; Akakpo PK; Mutocheluh M; Adjei-Danso E; Allornuvor G; Amoako-Sakyi D; Adu-Sarkodie Y; Mayaud P
    BMC Cancer; 2017 Oct; 17(1):688. PubMed ID: 29037188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of ezrin in human non-small cell lung cancer and its relationship with metastasis and prognosis].
    Chen QY; Yan J; Hu HZ; Chen FY; Song J; Jiang ZY; Jiao DM; Wu YQ
    Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):436-40. PubMed ID: 22967445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotyping for Human Papillomavirus (HPV) 16/18/52/58 Has a Higher Performance than HPV16/18 Genotyping in Triaging Women with Positive High-risk HPV Test in Northern Thailand.
    Khunamornpong S; Settakorn J; Sukpan K; Suprasert P; Srisomboon J; Intaraphet S; Siriaunkgul S
    PLoS One; 2016; 11(6):e0158184. PubMed ID: 27336913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [P16(INK4alpha)/Ki-67 immunocytochemical dual staining for detection of cervical lesions associated to papillomavirus infection].
    Toro de Méndez M; Ferrández Izquierdo A; Llombart-Bosch A
    Invest Clin; 2014 Sep; 55(3):238-48. PubMed ID: 25272523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of low-risk HPV infection for the risk of abnormal cervical cytology/histology in more than 40 000 Danish women.
    Nielsen A; Iftner T; Nørgaard M; Munk C; Junge J; Kjaer SK
    Sex Transm Infect; 2012 Dec; 88(8):627-32. PubMed ID: 22773328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt-11 overexpression promoting the invasion of cervical cancer cells.
    Wei H; Wang N; Zhang Y; Wang S; Pang X; Zhang S
    Tumour Biol; 2016 Sep; 37(9):11789-11798. PubMed ID: 27034261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus prevalence in paired urine and cervical samples in women invited for cervical cancer screening.
    Burroni E; Bonanni P; Sani C; Lastrucci V; Carozzi F; ; Iossa A; Andersson KL; Brandigi L; Di Pierro C; Confortini M; Levi M; Boccalini S; Indiani L; Sala A; Tanini T; Bechini A; Azzari C
    J Med Virol; 2015 Mar; 87(3):508-15. PubMed ID: 25418873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
    Hildesheim A; Schiffman MH; Tsukui T; Swanson CA; Lucci J; Scott DR; Glass AG; Rush BB; Lorincz AT; Corrigan A; Burk RD; Helgesen K; Houghten RA; Sherman ME; Kurman RJ; Berzofsky JA; Kramer TR
    Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):807-13. PubMed ID: 9332763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.